BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23084868)

  • 1. Reduction in the size of layered double hydroxide nanoparticles enhances the efficiency of siRNA delivery.
    Chen M; Cooper HM; Zhou JZ; Bartlett PF; Xu ZP
    J Colloid Interface Sci; 2013 Jan; 390(1):275-81. PubMed ID: 23084868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficiency of layered double hydroxide nanoparticle-mediated delivery of siRNA is determined by nucleotide sequence.
    Wong Y; Cooper HM; Zhang K; Chen M; Bartlett P; Xu ZP
    J Colloid Interface Sci; 2012 Mar; 369(1):453-9. PubMed ID: 22226499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silica nanoparticles and polyethyleneimine (PEI)-mediated functionalization: a new method of PEI covalent attachment for siRNA delivery applications.
    Buchman YK; Lellouche E; Zigdon S; Bechor M; Michaeli S; Lellouche JP
    Bioconjug Chem; 2013 Dec; 24(12):2076-87. PubMed ID: 24180511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-delivery of siRNAs and anti-cancer drugs using layered double hydroxide nanoparticles.
    Li L; Gu W; Chen J; Chen W; Xu ZP
    Biomaterials; 2014 Mar; 35(10):3331-9. PubMed ID: 24456604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,4-Butanediol diglycidyl ether (BDE)-crosslinked PEI-g-imidazole nanoparticles as nucleic acid-carriers in vitro and in vivo.
    Goyal R; Bansal R; Tyagi S; Shukla Y; Kumar P; Gupta KC
    Mol Biosyst; 2011 Jun; 7(6):2055-65. PubMed ID: 21505659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient siRNA delivery to mammalian cells using layered double hydroxide nanoparticles.
    Ladewig K; Niebert M; Xu ZP; Gray PP; Lu GQ
    Biomaterials; 2010 Mar; 31(7):1821-9. PubMed ID: 19922997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient delivery of siRNA to cortical neurons using layered double hydroxide nanoparticles.
    Wong Y; Markham K; Xu ZP; Chen M; Max Lu GQ; Bartlett PF; Cooper HM
    Biomaterials; 2010 Nov; 31(33):8770-9. PubMed ID: 20709387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-delivery of Se nanoparticles and pooled SiRNAs for overcoming drug resistance mediated by P-glycoprotein and class III β-tubulin in drug-resistant breast cancers.
    Zheng W; Yin T; Chen Q; Qin X; Huang X; Zhao S; Xu T; Chen L; Liu J
    Acta Biomater; 2016 Feb; 31():197-210. PubMed ID: 26612416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A unique and highly efficient non-viral DNA/siRNA delivery system based on PEI-bisepoxide nanoparticles.
    Swami A; Kurupati RK; Pathak A; Singh Y; Kumar P; Gupta KC
    Biochem Biophys Res Commun; 2007 Nov; 362(4):835-41. PubMed ID: 17822674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonviral pulmonary delivery of siRNA.
    Merkel OM; Kissel T
    Acc Chem Res; 2012 Jul; 45(7):961-70. PubMed ID: 21905687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
    Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
    Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chitosan-siRNA complex nanoparticles for gene silencing].
    Liu X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Feb; 27(1):97-101. PubMed ID: 20337033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functionalized layered double hydroxide nanoparticles conjugated with disulfide-linked polycation brushes for advanced gene delivery.
    Hu H; Xiu KM; Xu SL; Yang WT; Xu FJ
    Bioconjug Chem; 2013 Jun; 24(6):968-78. PubMed ID: 23682934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.
    Liu X; Howard KA; Dong M; Andersen MØ; Rahbek UL; Johnsen MG; Hansen OC; Besenbacher F; Kjems J
    Biomaterials; 2007 Feb; 28(6):1280-8. PubMed ID: 17126901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
    Spagnou S; Miller AD; Keller M
    Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing.
    Kong F; Liu G; Sun B; Zhou S; Zuo A; Zhao R; Liang D
    Int J Pharm; 2012 Jan; 422(1-2):445-53. PubMed ID: 22067703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective stabilization and delivery of siRNA: reversible siRNA-phospholipid conjugate in nanosized mixed polymeric micelles.
    Musacchio T; Vaze O; D'Souza G; Torchilin VP
    Bioconjug Chem; 2010 Aug; 21(8):1530-6. PubMed ID: 20669936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly-L-lysine functionalized large pore cubic mesostructured silica nanoparticles as biocompatible carriers for gene delivery.
    Hartono SB; Gu W; Kleitz F; Liu J; He L; Middelberg AP; Yu C; Lu GQ; Qiao SZ
    ACS Nano; 2012 Mar; 6(3):2104-17. PubMed ID: 22385282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A serum-tolerant hydroxyl-modified polyethylenimine as versatile carriers of pDNA/siRNA.
    Dong X; Lin L; Chen J; Guo Z; Tian H; Li Y; Wei Y; Chen X
    Macromol Biosci; 2013 Apr; 13(4):512-22. PubMed ID: 23300130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Layered double hydroxide nanoparticles as target-specific delivery carriers: uptake mechanism and toxicity.
    Choi SJ; Choy JH
    Nanomedicine (Lond); 2011 Jul; 6(5):803-14. PubMed ID: 21793673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.